Search research articles
Contact Us
Filters
Showing results (431-440 of 436) with videos related to
Page
of 44
Sort By:
You have reached the last page of results.
This site can display upto 436 results.
Circulation
|
August 21, 2023
Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial
Frederik M Zimmermann, Victoria Y Ding, Nico H J Pijls, et al.
Lancet (London, England)
|
April 2, 2025
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial
William F Fearon, Frederik M Zimmermann, Victoria Y Ding, et al.
The New England Journal of Medicine
|
November 4, 2021
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery
William F Fearon, Frederik M Zimmermann, Bernard De Bruyne, et al.
Lancet Regional Health. Americas
|
February 23, 2023
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium
Toni K Choueiri, Chris Labaki, Ziad Bakouny, et al.
The New England Journal of Medicine
|
April 1, 2020
Initial Invasive or Conservative Strategy for Stable Coronary Disease
David J Maron, Judith S Hochman, Harmony R Reynolds, et al.
Cancer
|
February 20, 2024
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study
Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, et al.
Page
of 44
Search research articles
Search
Showing results (431-440 of 436) with videos related to
Sort By:
Page
of 44
You have reached the last page of results.
This site can display upto 436 results.
Circulation
|
August 21, 2023
Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial
Frederik M Zimmermann, Victoria Y Ding, Nico H J Pijls, et al.
Lancet (London, England)
|
April 2, 2025
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial
William F Fearon, Frederik M Zimmermann, Victoria Y Ding, et al.
The New England Journal of Medicine
|
November 4, 2021
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery
William F Fearon, Frederik M Zimmermann, Bernard De Bruyne, et al.
Lancet Regional Health. Americas
|
February 23, 2023
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium
Toni K Choueiri, Chris Labaki, Ziad Bakouny, et al.
The New England Journal of Medicine
|
April 1, 2020
Initial Invasive or Conservative Strategy for Stable Coronary Disease
David J Maron, Judith S Hochman, Harmony R Reynolds, et al.
Cancer
|
February 20, 2024
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study
Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, et al.
Page
of 44